Primitive Ventures
VC Fund
San Francisco, United States
Primitive Ventures is a global venture investment firm with a focus on blockchain and related technologies. At Primitive, we're proudly thesis-free, and instead spend all of their waking hours finding and supporting the people building truly valuable things.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 2%
Last updated:
For AI agents: llms.txt
Industries Primitive Ventures invests in
Stages Primitive Ventures invests in
Countries Primitive Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2M–$60M
- Series A
- $5.1M–$21M
Investment Focus
Industry
- Blockchain 20 (44%)
- Cryptocurrency 11 (24%)
- Software 9 (20%)
- Information Technology 9 (20%)
- Financial Services 7 (16%)
Stage
- Seed 23 (51%)
- Series A 9 (20%)
- Pre-Seed 2 (4%)
- Series B 2 (4%)
- Funding Round 2 (4%)
Country
- United States 14 (31%)
- Singapore 7 (16%)
- Hong Kong 3 (7%)
- Israel 2 (4%)
- United Arab Emirates 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dovey Wan
Founding Partner
|
Founding Partner | Total investments: 36 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cycles functions as a decentralized clearinghouse and reduces outstanding short-term obligations before settlement. | $6.4M / Seed / May 21, 2026 | ||
| Opinion Labs is a decentralized intelligence platform. It has developed O.LAB which provides financial information and intelligence. Its products encompass prediction and opinion markets. | $20M / Seed / Feb 05, 2026 | ||
| aPriori is a monad-native MEV infrastructure and liquid staking mechanism developed for parallel executions. | $20M / Series A / Aug 28, 2025 | ||
| OpenMind is a software company that develops an operating system for robots and intelligent machines. | $20M / Series A / Aug 04, 2025 | ||
| MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company’s clinical development pipeline includes lead drug candidate Pracinostat, a potential best-in-class, oral histone deacetylase (HDAC) inhibitor. Pracinostat has been tested in more than 150 patients inmultiple Phase I and exploratory Phase II clinical trials, including advanced hematologic malignancies such as myelodysplastic syndrome, acute myeloid leukemia and myelofibrosis. The Company expects to initiate a randomized Phase II trial of Pracinostat in combination with standard-of-care in at least one hematologic malignancy toward the middle of 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. Results from a Phase I trial of intravenous ME-143 in heavily treated patients with solid refractory tumors were presented at the American Society of Clinical Oncology Annual Meeting in June 2012. A Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors is ongoing. | $100M / Post-IPO Equity / Jul 18, 2025 | ||
| SharpLink is an online technology company that works with sports leagues, fantasy sports sites, and sports media companies. | $425M / Post-IPO Equity / May 27, 2025 | ||
| SpaceComputer uses satellites to create a secure blockchain system that resists cyberattacks and physical tampering. | Pre-Seed / May 13, 2025 | ||
| Henlo.com is a memecoin project that relies on community involvement and is part of the Berachain ecosystem. | $3M / Seed / Feb 05, 2025 | ||
| Canopy is a DeFi platform built on Movement that leverages a dynamically balanced dual-token ecosystem of $LEAF and $OAK, as well as the ability for users to offer liquidity with single asset deposits. | $1.2M / Seed / Jan 29, 2025 | ||
| TAC is a TON network extension that allows the EVM community to access Telegram users, and it enables Ton wallet holders to easily interact with EVM dApps deployed on TAC. | $6.5M / Seed / Nov 11, 2024 | ||
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Primitive Ventures invest in?
Primitive Ventures invests primarily in Blockchain, Cryptocurrency and Software startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Primitive Ventures invest in?
Primitive Ventures typically joins rounds of $2M–$60M at Seed and $5.1M–$21M at Series A. These are whole funding-round sizes, not Primitive Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Primitive Ventures took part in.
How do I contact Primitive Ventures?
Public channels for Primitive Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Primitive Ventures?
The team at Primitive Ventures includes Dovey Wan (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
